Nanobiotix annual return on equity
2019
2020
2021
Nanobiotix Return on Equity (ROE) Growth & History (NANO)
Nanobiotix's return on equity was −96.66% for fiscal 2021.
View full Nanobiotix company overviewNanobiotix annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | −96.66% | +1.33 pp |
| 2020 | 2020-12-31 | −97.99% | +727.55 pp |
| 2019 | 2019-12-31 | −825.54% | — |
Nanobiotix return on equity trends
Between the periods ended 2019-12-31 and 2021-12-31, Nanobiotix's return on equity increased from −825.54% to −96.66%, a change of +728.88 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nanobiotix source filings ↗